Zalviso is an innovative delivery system for sublingual sufentanil self-administration via a hand-held device to be used in a hospital setting only. Zalviso is indicated for the management of acute moderate to severe post-operative pain in adult patients.  Zalviso should only be prescribed by physicians who are experienced in the management of opioid therapy, particularly opioid adverse reactions such as respiratory depression.

The Zalviso Resource Centre will provide you with information about the device and useful materials to assist you in using Zalviso in a post-operative setting.